全文获取类型
收费全文 | 11991篇 |
免费 | 904篇 |
国内免费 | 439篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 231篇 |
妇产科学 | 17篇 |
基础医学 | 776篇 |
口腔科学 | 5篇 |
临床医学 | 1119篇 |
内科学 | 1988篇 |
皮肤病学 | 32篇 |
神经病学 | 25篇 |
特种医学 | 164篇 |
外科学 | 2391篇 |
综合类 | 3092篇 |
现状与发展 | 4篇 |
预防医学 | 387篇 |
眼科学 | 30篇 |
药学 | 1442篇 |
12篇 | |
中国医学 | 1583篇 |
肿瘤学 | 30篇 |
出版年
2024年 | 48篇 |
2023年 | 146篇 |
2022年 | 304篇 |
2021年 | 487篇 |
2020年 | 389篇 |
2019年 | 320篇 |
2018年 | 362篇 |
2017年 | 401篇 |
2016年 | 468篇 |
2015年 | 545篇 |
2014年 | 948篇 |
2013年 | 921篇 |
2012年 | 969篇 |
2011年 | 977篇 |
2010年 | 699篇 |
2009年 | 619篇 |
2008年 | 638篇 |
2007年 | 591篇 |
2006年 | 552篇 |
2005年 | 509篇 |
2004年 | 387篇 |
2003年 | 315篇 |
2002年 | 254篇 |
2001年 | 229篇 |
2000年 | 170篇 |
1999年 | 127篇 |
1998年 | 110篇 |
1997年 | 122篇 |
1996年 | 96篇 |
1995年 | 86篇 |
1994年 | 77篇 |
1993年 | 74篇 |
1992年 | 67篇 |
1991年 | 38篇 |
1990年 | 42篇 |
1989年 | 49篇 |
1988年 | 48篇 |
1987年 | 35篇 |
1986年 | 21篇 |
1985年 | 25篇 |
1984年 | 23篇 |
1983年 | 6篇 |
1982年 | 7篇 |
1981年 | 7篇 |
1980年 | 6篇 |
1979年 | 3篇 |
1978年 | 3篇 |
1975年 | 3篇 |
1973年 | 3篇 |
1970年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
目的:探究替米沙坦对冠心病合并糖尿病肾病患者疗效的影响情况。方法:56例探究目标对象均为某院接收的冠心病合并糖尿病肾病患者,挑选时间2018年6月~2019年6月。将"计算机表法"作为分组的参考,分配为参照组(n=28例)执行依那普利治疗,探究组(n=28例)执行替米沙坦治疗。结果:探究组的LVEF、LVEDd、肌酐、24h尿蛋白4项指标与参照组相比,差异有统计学意义(P<0.05);收缩压、舒张压、空腹血糖、餐后2h血糖4项指标与参照组相比,差异没有统计学意义(P>0.05)。结论:冠心病合并糖尿病肾病患者选择替米沙坦治疗后,心室功能的重构以及肾脏预后结局均得到改善,且临床效果比依那普利好,值得借鉴。 相似文献
2.
3.
糖尿病肾内动脉血流动力学改变的研究 总被引:1,自引:0,他引:1
目的:观察糖尿病肾病不同时期肾内分级动脉血流动力学的改变。方法:用脉冲多普勒方法分别测量正常对照组、糖尿病正常蛋白尿阶段,隐匿性肾病.临床糖尿病肾病肾功能代偿期及糖尿病肾病肾功失代偿期各组肾内分级动脉Vmax、Vmin、TAMX、PI、RI血流参数.并与对照组比较。结果:糖尿病不同时期Vmax均增高.与正常对照组有显著性差异;Vmin随着病程的发展.逐渐减低;PI、RI随病情的进展逐渐增高.尤以糖尿病肾病肾功能代偿期及肾病肾功失代偿期明显。结论:多普勒超声是一种简便、直观、快速非创伤性检查糖尿病血流动力学改变的方法.通过对肾内分级动脉血流参数的观察.尤其是PI、RI的变化,判断糖尿病肾损害的程度。 相似文献
4.
Ronald J. Hogg Fred G. Silva Philip L. Berry James E. Wenz 《Pediatric nephrology (Berlin, Germany)》1993,7(1):27-31
We report clinical and pathological data in 56 adolescents presenting with gross hematuria (GH) and 65 presenting with idiopathic nephrotic syndrome (INS). IgA nephropathy (present in 52%) and other mesangial lesions were found in the majority of the 56 patients with GH. Many of these patients had complex urological procedures prior to consideration of a nephrological problem. This often led to significant delays in making the appropriate diagnosis. Pathological lesions in the 65 patients with INS included minimal change NS (MCNS) in 31%, membranous glomerulonephritis (MGN) and focal segmental glomerulosclerosis (FSGS) in 18.5% each, and membranoproliferative GN (MPGN) in 12%. In 47 of the patients with INS, in whom no specific treatment had been given prior to renal biopsy, MCNS and MGN were observed with a similar frequency (26% and 23%, respectively), with FSGS and MPGN being found in 21% and 11%. These results indicate that the pathological lesions in adolescents with INS who undergo a renal biopsy more closely resemble those in adults, and are usually more severe than those in young children. However, it should be noted that our study was retrospective. Hence, there were probably some adolescents with INS who had a successful response to therapy and therefore did not have a renal biopsy performed.
Southwest Pediatric Nephrology Study Group (Central Office, Baylor University Medical Center at Dallas, Tex., USA). Director, Ronald J. Hogg; Associate Directors, Fred G. Silva and F. Bruder Stapleton; Statistician, Joan S. Reisch; Administrative Assistant, Kaye Green. Participating Centers—Baylor College of Medicine, Houston, Tex.: Phillip L. Berry, L. Leighton Hill, Sami A, Sanjad, Edith Hawkins; Baylor University Medical Center, Dallas, Tex.: Ronald J. Hogg, Kaye Green; Tulane University Medical Center, New Orleans, La.: Frank Boineau, John E. Lewy, Radhakrishna Baliga, Patrick Walker; University of Arkansas, Little Rock, Ark.: Watson Arnold, Eileen Ellis, Edward Uthman; University of Colorado Health Science Center, Denver, Colo.: Gary M. Lum, Wiliam Hammond; University of Oklahoma Medical Center, Oklahoma City, Okla.: James Wenzl, James Matson, Geoffrey Altshuler, Sarah Johnson; University of Tennessee, Memphis, Tenn.: F. Bruder Stapleton, Shane Roy, III, Robert J. Wyatt, Charles McKay, William Murphy; University of Texas Health Science Center at Dallas, Tex.: Billy S. Arant Jr, Michel Baum, Fred G. Silva, Arthur Weinberg, Craig Argyle, Joseph Rutledge, Ed Eigenbrodt; University of Texas Medical School, Houston, Tex.: Susan B. Conley, Jacques Lemine, Ron Portman, Ann Ince, Regina Verani; University of Texas Health Science Center at San Antonio, Tex.: Michael Foulds, Sudesh Makker, Kanwal Kher, Melanie Sweet, Victor Saldivar, Fermin Tio; University of Texas Medical Branch, Galveston, Tex.: Ben H. Brouhard, Alok Kalia, Luther B. Travis, Lisa Hollander, Tito Cavallo, Srinivasan Rajaraman; University of Utah Medical Center, Salt Lake City; Utah: Eileen Brewer, Richard Siegler, Elizabeth Hammond, Theodore Pysher.
Note that this list reflects the investigators' addresses and positions during the period of this study and not necessarily their current situations. 相似文献
5.
糖尿病大鼠肺病理改变及同期肾脏病理变化对比 总被引:3,自引:0,他引:3
目的:观察糖尿病(DM)大鼠肺组织改变及与同期肾脏变化的关系.方法:链脲菌素腹腔注射制作糖尿病大鼠模型,4周后胶原、网状纤维染色及透射电镜方法观察糖尿病大鼠肺组织基底膜病理改变,同期观察肾脏改变.结果:DM大鼠4周后肺组织病理改变为毛细血管基底膜及Ⅱ型肺泡上皮细胞基底膜不同程度的增厚及肺间质胶原成分等细胞外基质的增多,与同期糖尿病肾脏病变相平行.结论:DM大鼠4周后肺组织与糖尿病肾病相似,主要表现为微血管病变. 相似文献
6.
Y Namba T Moriyama M Kyo K Oka Y Kokado Y Shi R Imamura N Ichimaru A Okuyama S Takahara 《Clinical transplantation》2004,18(S11):29-33
Abstract: Angiotensin-converting enzyme inhibitor (ACEI) has become recognized as agents that have renoprotective effects in the treatment of progressive renal diseases including post-transplant kidneys. Previously we demonstrated the safety and effectiveness of ACEI treatment on the hypertensive proteinuric post-transplant patients ( N = 10) who had been followed up for 12 months. However, not all patients show good response in urinary protein reduction. We aimed to analyse the histopathological factor(s) affecting the responsiveness of proteinuria to ACEI treatment. Fourteen post-transplant patients with proteinuria who were treated with ACEI and underwent allograft biopsy were analysed. Eight patients showed 50% or more reduction in proteinuria (responder). The other 6 patients showed less (< 50%) reduction in proteinuria (non-responder). There was no difference in clinical characteristics (BP, renal function, donor age, recipient body mass index), dietary sodium or protein intake, and diuretic use between the two groups. As a histopathological characteristic, glomerular size in responder group was significantly larger than that in non-responder group. This suggests that the large glomerular size at least partly contributes to the responsiveness in urinary protein reduction to ACEI treatment in kidney allograft recipients with proteinuria. 相似文献
7.
8.
Masanori Hara M.D. Reiko Yoshida M.D. Susumu Inaba M.D. Akira Higuchi M.D. Yoshifumi Suzuki M.D. Toshio Okada M.D. Takakuni Tanizawa M.D. 《Pediatrics international》1991,33(3):335-344
The aim of this study was to assess the significance of C3 deposition in IgA nephropathy in children and adolescents. One hundred and two patients aged 5–21 years (57 male and 45 female) were studied. The findings of C3 deposition were classified into 8 groups by immunofluorescent (IF) pattern and intensity as follows: group MC3+ (N = 12): mesangiocapillary pattern and 3+ in intensity; group MC2+ (N = 13): mesangiocapillary and 2+; group MC1 + (N = 4): mesangiocapillary and 1 +; group M3+ (N = 11): mesangial and 3+; group M2+ (N = 24): mesangial and 2+; group M1 + (N=18): mesangial 1 +; group S (N = 12): only segmentally positive; and group N (N = 8): negative. Histological changes were scored semiquantitatively as an activity index (cellular proliferation, necrosis, interstitial cell infiltration, and cellular crescents) and a chronicity index (mesangial sclerosis, segmental and global glomerular sclerosis, fibrous crescents, adhesion and tubulo-interstitial change). IF findings were scored semiquantitatively and laboratory findings were also studied. The following results were obtained: 1) The scores of total activity index in MC groups were higher than in the M, S or N groups, and the greater the degree of C3 deposition, the higher the score; 2) Such result was not evident in the chronicity index; 3) High IF scores of IgG and IgM were found in the MC3+ and MC2+ groups; 4) Hematuria was more severe in MC3+ and MC2+ than in other groups, and proteinuria was more prominent in the MC than other groups. Thus the degree of C3 deposition was parallel with histological activity and urinary findings. 相似文献
9.
R S Nanra 《Nephrology, dialysis, transplantation》1992,7(5):384-390
Comprehensive renal function tests were performed in 84 patients with analgesic nephropathy, 33 glomerulonephritis patients matched for creatinine clearance, and 30 control subjects. A system of 1-day renal function tests including urine microscopy, creatinine clearance, phenolsulphonphthalein excretion, urine concentration and acidification, and electrolyte excretion, was used. Patients with analgesic nephropathy were found to have significant sterile pyuria and haematuria, even those with mild renal insufficiency, significantly reduced concentrating ability and a distal acidifying defect, and a tendency to impaired sodium conservation. These function defects are consistent with the primary lesion of renal papillary necrosis in analgesic nephropathy; the detection of these defects have implications in patient management. 相似文献
10.
以辣根过氧化物酶(PO)和抗-PO作为免疫沉淀中的抗原和抗体,用光电比色法,对78例小儿肾脏疾病血清补体对免疫沉淀的抑制作用(IIPC)进行了研究,并同时检测补体成分C3、C4。结果,正常对照IIPCOD值为0.505±0.085,急性肾小球肾炎(0.137±0.108)显著降低(P<0.001);慢性肾小球肾炎(0.470±0.053)改变不明显(P>0.05);肾病综合征(0.401±0.038)明显低下(P<0.05)。IIPC低下的发生率依次为急性肾小球肾炎(83%)、肾病综合征(43%)、慢性肾小球肾炎(32%)。表明小儿肾小球疾病时IIPC大多降低并与疾病的活动性有关。因此认为IIPC低下在肾脏病的发生和发展中起一定作用。 相似文献